Pros and cons of adjuvant interferon in the treatment of melanoma.
about
Antiproliferative Properties of Type I and Type II Interferon.New insights into IL-12-mediated tumor suppression.Photosensitizing and radiosensitizing effects of mitoxantrone: combined chemo-, photo-, and radiotherapy of DFW human melanoma cells.Enhanced anti-melanoma efficacy of interferon alfa-2b via inhibition of Shp2.Adjuvant therapy for malignant melanoma.Biomarkers in melanoma: stage III and IV disease.Choices in adjuvant therapy of melanoma.Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma.The role of the CTLA4 blockade in the treatment of malignant melanoma.Adjuvant therapy of melanoma with interferon: lessons of the past decadeToll-like receptor 9 (TLR9) agonists in the treatment of cancer.Loss of the eukaryotic initiation factor 3f in melanoma.Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node.Molecular markers of tumor progression in melanoma.Novaferon, a novel recombinant protein produced by DNA-shuffling of IFN-α, shows antitumor effect in vitro and in vivo.Potential applications of nanoshells in biomedical sciences.Adjuvant high-dose interferon-{alpha} for resected melanoma in a patient with HIV infection.A randomised trial evaluating bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update.Introducing MARCo: Histoserological Findings of a Multi-Organic Paraneoplastic Syndrome in Cutaneous Melanoma Patients.Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer.The abundance of metabolites related to protein methylation correlates with the metastatic capacity of human melanoma xenografts.The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.Potassium Ascorbate with Ribose: Promising Therapeutic Approach for Melanoma Treatment.ING3 promotes UV-induced apoptosis via Fas/caspase-8 pathway in melanoma cells.Enhanced anti-melanoma efficacy of interferon α-2b via overexpression of ING4 by enhanced Fas/FasL-mediated apoptosis.Adjuvant treatment for stage III melanoma in the era of targeted medicine and immunotherapy
P2860
Q34007700-5DCCC5D7-9649-42E5-8452-81D1B9F996BFQ34436897-9F54504F-4352-431B-A957-B07AC6A495CAQ34570501-7EA9B593-0B13-4E0C-BF3D-81DCAB1EB588Q35871624-62186CD7-32B5-4D6A-8691-4D72B5835018Q35918453-6F70FB29-B911-4102-AB27-741CD2A7847DQ36050541-E5429637-2726-4517-A08F-05254FF95809Q36301110-2F969619-BBB2-4841-867C-AB56A45B2889Q36927476-F45166DF-E1CD-4775-9DF6-3040133DF0E3Q37008621-34878D89-9192-4953-9B85-4531E3F8E444Q37021067-3CB7A196-A057-4E21-A2CC-C33AF01F3EF6Q37050998-4FB4FEC4-4B4F-40DC-A6CB-A6C51E4F3ED2Q37083955-5BA57EC3-F9AC-4A5F-B3D2-CB4E649BAEA6Q37442008-0881D789-D6F3-4A55-B597-81415320CC06Q37641784-BEFDAE07-E01B-4820-B677-990E953DB056Q37685335-5BB6AFE9-9EA8-4759-8F5C-14D48726507CQ38149992-8512EB1F-4245-45A2-BFDF-9E0680919FD6Q39508180-03BEBDD0-95D9-4048-A00D-673E69876FEFQ39690446-8F001E42-4ECB-40E8-B6E1-E5A95BCA635AQ42364290-B2D58F8C-CC0F-4B1F-AE01-C9A59C01D6F6Q42560945-CB4A9CD5-CAB7-458D-A855-0CF55895B359Q43091953-501D39F1-F08D-4EE3-BAAA-C42532EAC2CFQ46445396-FC8783B4-41F1-4DA3-9F33-5EA4D099EF7CQ47151869-E58E89B4-67C6-4C41-9C42-749C7A61FA61Q53132557-8931BB85-0DE4-4374-BF7B-95DF63D7CDEAQ54967270-E0C2EBB0-B06F-4194-98F5-85A8BEB39DDFQ56895044-62FBF52C-6A2A-465C-8283-0526E32B8FC5
P2860
Pros and cons of adjuvant interferon in the treatment of melanoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Pros and cons of adjuvant interferon in the treatment of melanoma.
@ast
Pros and cons of adjuvant interferon in the treatment of melanoma.
@en
type
label
Pros and cons of adjuvant interferon in the treatment of melanoma.
@ast
Pros and cons of adjuvant interferon in the treatment of melanoma.
@en
prefLabel
Pros and cons of adjuvant interferon in the treatment of melanoma.
@ast
Pros and cons of adjuvant interferon in the treatment of melanoma.
@en
P1433
P1476
Pros and cons of adjuvant interferon in the treatment of melanoma.
@en
P2093
Michael S Sabel
Vernon K Sondak
P304
P356
10.1634/THEONCOLOGIST.8-5-451
P577
2003-01-01T00:00:00Z